Pharmacology and Toxicology

Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro

1. Xiaoyan Pan
2. Pengfei Zhou
3. Tiejiong Fan
4. Yan Wu
5. Jing Zhang
6. Xiaoyue Shi
7. Weijuan Shang
8. Lijuan Fang
9. Xiaming Jiang
10. Jian Shi
11. Yuan Sun
12. Shaojuan Zhao
13. Rui Gong
14. Ze Chen
15. Gengfu Xiao

Reviewed by ScreenIT

Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice

1. N.V Rajeshkumar
2. Shinichi Yabuuchi
3. Shweta G. Pai
4. Anirban Maitra
5. Manuel Hidalgo
6. Chi V. Dang

Reviewed by ScreenIT

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase

1. Jingyue Ju
2. Xiaoxu Li
3. Shiv Kumar
4. Steffen Jockusch
5. Minchen Chien
6. Chuanjuan Tao
7. Irina Morozova
8. Sergey Kalachikov
9. Robert N. Kirchdoerfer
10. James J. Russo

Reviewed by ScreenIT

AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2

1. Bowen Tang
2. Fengming He
3. Dongpeng Liu
4. Fei He
5. Tong Wu
6. Meijuan Fang
7. Zhangming Niu
8. Zhen Wu
9. Dong Xu

Reviewed by ScreenIT

Local generation and efficient evaluation of numerous drug combinations in a single sample

1. Vlad Elgart
2. Joseph Loscalzo

• Curated by eLife

  eLife assessment

  In this manuscript, a method to test a large number of drug combinations in a single cell culture sample is presented. The strength of the evidence lies in their multiple experiments with different combinations of agents. The paper suggests that results from this application are feasible and the methodology could be applied in other laboratories to use drug combinations for defined outcomes.

Reviewed by eLife

The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury

1. Amy Louise Ball
2. Carol E Jolly
3. Mark G Lennon
4. Jonathan J Lyon
5. Ana Alfirevic
6. Amy E Chadwick

• Curated by eLife

  eLife assessment

  This paper is of potential interest to scientists within the field of drug-induced liver injury. The concept of the study is interesting by generating mitochondrial genotype-specific liver cell lines to evaluate idiosyncratic hepatotoxicity. While the proof-of-concept is clearly presented, the current data do not yet allow to draw broad conclusions about the significance of the study in terms of drug effects.

Reviewed by eLife

Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics

1. Ziva Vuckovic
2. Jinan Wang
3. Vi Pham
4. Jesse I Mobbs
5. Matthew J Belousoff
6. Apurba Bhattarai
7. Wessel AC Burger
8. Geoff Thompson
9. Mahmuda Yeasmin
10. Vindhya Nawaratne
11. Katie Leach
12. Emma T van der Westhuizen
13. Elham Khajehali
14. Yi-Lynn Liang
15. Alisa Glukhova
16. Denise Wootten
17. Craig W Lindsley
18. Andrew Tobin
19. Patrick Sexton
20. Radostin Danev
21. Celine Valant
22. Yinglong Miao
23. Arthur Christopoulos
24. David M Thal

• Curated by eLife

  eLife assessment

  This fundamental study is important and carefully executed, providing important insights into the allosteric regulation of GPCRs with exceptional strength of evidence. This work will be of interest to a wide audience in drug discovery and receptor biology. The major strengths are the comprehensive structural and pharmacological characterization with only minor weaknesses, most notably a concern regarding the approach used to quantify efficacy.

Reviewed by eLife

Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance

1. Can Liu
2. Jiawei Zhou
3. Stephan Kudlacek
4. Timothy Qi
5. Tyler Dunlap
6. Yanguang Cao

• Curated by eLife

  eLife assessment

  The authors have developed a useful model for how proteins that mediate a connection between invariant components of the T cell antigen receptor and leukaemic cells antigens, called bispecific engagers (BiTEs), mediate immunological synapse formation and impact T cell search for tumour cells in vivo. The model was compared against the in vitro experiments and in vivo data following a solid approach. The developed framework could provide a direction for employing computational mechanistic models for evaluating various strategies for BiTE treatments.

Reviewed by eLife

A mechanism of uncompetitive inhibition of the serotonin transporter

1. Shreyas Bhat
2. Ali El-Kasaby
3. Ameya Kasture
4. Danila Boytsov
5. Julian B Reichelt
6. Thomas Hummel
7. Sonja Sucic
8. Christian Pifl
9. Michael Freissmuth
10. Walter Sandtner

• Curated by eLife

  eLife assessment

  This study presents the important finding of an unusual uncompetitive inhibitor (ECSI#6) of the serotonin transporter that removes the neurotransmitter serotonin from the synaptic cleft. Through careful and comprehensive analysis, the authors convincingly show that the molecule most likely binds to the inward-facing and K+-bound state and that it assists in folding and targeting the transporter. The work will be of interest to those engaged in biophysical analyses of the serotonin transporter, and colleagues developing pharmacological chaperoning strategies for transporters in general.

Reviewed by eLife

Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals

1. Lijuan Xu
2. Xinyao Zhang
3. Yin Zhao
4. Xiaorui Gang
5. Tao Zhou
6. Jialing Han
7. Yang Cao
8. Binyan Qi
9. Shuning Song
10. Xiaojie Wang
11. Yuanbo Liang

• Curated by eLife

  eLife assessment

  This manuscript proposes that metformin protects against elevated intraocular pressure and oxidative injury by regulating cytoskeleton remodeling through the integrin/ROCK pathway, thus providing a new direction for further exploration toward the treatment of primary open-angle glaucoma as well as investigation of oxidative injury in multiple settings.

Reviewed by eLife